179 related articles for article (PubMed ID: 32526335)
1. Hyaluronic acid and antimicrobial peptide-modified gold/silver hybrid nanocages to combat bacterial multidrug resistance.
Yang J; Zhao Y; Cao J; Gong C; Zuo J; Zhang N; Zhao Y
Int J Pharm; 2020 Aug; 586():119505. PubMed ID: 32526335
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial Activity of Gold Nanoparticles Conjugated by Aminoglycosides Against
Rad MR; Kazemian H; Yazdani F; Monfared MRZ; Rahdar H; Javadi A; Kodori M
Recent Pat Antiinfect Drug Discov; 2018; 13(3):256-264. PubMed ID: 30152290
[TBL] [Abstract][Full Text] [Related]
3. Silver nanoparticles synthesized with Eucalyptus critriodora ethanol leaf extract stimulate antibacterial activity against clinically multidrug-resistant Acinetobacter baumannii isolated from pneumonia patients.
Wintachai P; Paosen S; Yupanqui CT; Voravuthikunchai SP
Microb Pathog; 2019 Jan; 126():245-257. PubMed ID: 30445131
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Evaluation of Antimicrobial Peptide Tridecaptin M in Combination with Other Antibiotics against Multidrug Resistant
Jangra M; Raka V; Nandanwar H
Molecules; 2020 Jul; 25(14):. PubMed ID: 32708842
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii.
Mutlu Yilmaz E; Sunbul M; Aksoy A; Yilmaz H; Guney AK; Guvenc T
Int J Antimicrob Agents; 2012 Oct; 40(4):332-6. PubMed ID: 22831842
[TBL] [Abstract][Full Text] [Related]
6. Gold nanoparticle-DNA aptamer-assisted delivery of antimicrobial peptide effectively inhibits Acinetobacter baumannii infection in mice.
Park J; Shin E; Yeom JH; Choi Y; Joo M; Lee M; Kim JH; Bae J; Lee K
J Microbiol; 2022 Jan; 60(1):128-136. PubMed ID: 34964948
[TBL] [Abstract][Full Text] [Related]
7. Confronting multidrug-resistant Acinetobacter baumannii: a review.
Neonakis IK; Spandidos DA; Petinaki E
Int J Antimicrob Agents; 2011 Feb; 37(2):102-9. PubMed ID: 21130607
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic Acid-Modified Au-Ag Alloy Nanoparticles for Radiation/Nanozyme/Ag
Chong Y; Huang J; Xu X; Yu C; Ning X; Fan S; Zhang Z
Bioconjug Chem; 2020 Jul; 31(7):1756-1765. PubMed ID: 32463680
[TBL] [Abstract][Full Text] [Related]
9. Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam.
Pachón-Ibáñez ME; Fernández-Cuenca F; Docobo-Pérez F; Pachón J; Pascual A
J Antimicrob Chemother; 2006 Sep; 58(3):689-92. PubMed ID: 16870647
[TBL] [Abstract][Full Text] [Related]
10. Core-shell-shell nanorods for controlled release of silver that can serve as a nanoheater for photothermal treatment on bacteria.
Hu B; Wang N; Han L; Chen ML; Wang JH
Acta Biomater; 2015 Jan; 11():511-9. PubMed ID: 25219350
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology as a therapeutic tool to combat microbial resistance.
Pelgrift RY; Friedman AJ
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
[TBL] [Abstract][Full Text] [Related]
12. Effects of specific egg yolk immunoglobulin on pan-drug-resistant Acinetobacter baumannii.
Shi H; Zhu J; Zou B; Shi L; Du L; Long Y; Wang H; Xu H; Zhen Y; Sun L
Biomed Pharmacother; 2017 Nov; 95():1734-1742. PubMed ID: 28962078
[TBL] [Abstract][Full Text] [Related]
13. Efflux pump inhibitory activity of biologically synthesized silver nanoparticles against multidrug-resistant Acinetobacter baumannii clinical isolates.
Behdad R; Pargol M; Mirzaie A; Karizi SZ; Noorbazargan H; Akbarzadeh I
J Basic Microbiol; 2020 Jun; 60(6):494-507. PubMed ID: 32301139
[TBL] [Abstract][Full Text] [Related]
14. Is tigecyclin a good choice in the treatment of multidrug-resistant Acinetobacter baumannii pneumonia?
Tasbakan MS; Pullukcu H; Sipahi OR; Tasbakan MI; Aydemir S; Bacakoglu F
J Chemother; 2011 Dec; 23(6):345-9. PubMed ID: 22233818
[TBL] [Abstract][Full Text] [Related]
15. Silica-Coated Gold-Silver Nanocages as Photothermal Antibacterial Agents for Combined Anti-Infective Therapy.
Wu S; Li A; Zhao X; Zhang C; Yu B; Zhao N; Xu FJ
ACS Appl Mater Interfaces; 2019 May; 11(19):17177-17183. PubMed ID: 30997794
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia.
Tang HJ; Chuang YC; Ko WC; Chen CC; Shieh JM; Chen CH; Lee NY; Chiang SR
Int J Infect Dis; 2012 Jan; 16(1):e34-40. PubMed ID: 22088863
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic effect of phages on extensively drug-resistant Acinetobacter baumannii-induced sepsis in mice].
Deng LY; Yang ZC; Gong YL; Huang GT; Yin SP; Jiang B; Peng YZ
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):523-8. PubMed ID: 27647067
[TBL] [Abstract][Full Text] [Related]
18. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
Kwa AL; Loh C; Low JG; Kurup A; Tam VH
Clin Infect Dis; 2005 Sep; 41(5):754-7. PubMed ID: 16080101
[TBL] [Abstract][Full Text] [Related]
19. Current review of antimicrobial treatment of nosocomial pneumonia caused by multidrug-resistant pathogens.
Jean SS; Hsueh PR
Expert Opin Pharmacother; 2011 Oct; 12(14):2145-8. PubMed ID: 21895553
[TBL] [Abstract][Full Text] [Related]
20. Intratracheal colistin sulfate for BALB/c mice with early pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
Chiang SR; Chuang YC; Tang HJ; Chen CC; Chen CH; Lee NY; Chou CH; Ko WC
Crit Care Med; 2009 Sep; 37(9):2590-5. PubMed ID: 19623044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
